Strukova S M, Umarova B A, Gribkova N N, Kudriashov B A
Biull Eksp Biol Med. 1980 Mar;89(3):270-2.
Prethrombin 2, and immediate precursor of thrombin, was obtained by limited trypsin or active factor X proteolysis by prethrombin 1. The conversion of prethrombin 1 to prethrombin 2 does not occur in the absence of enzymes. It has been shown that factor V has no influence on the rate of thrombin generation from prethrombin 2 and that prethrombin itself has no coagulant or esterase activity. Intravenous injection of prethrombin 2 preparations led to an increase in plasma recalcification time, overall fibrinolytic activity and non-enzymatic fibrinolysis. In addition, there was observed a considerable increase in fibrinogen-heparin complex activity. The data obtained indicate excitation of the anticoagulant system with intravenous injection of small doses of prethrombin 2.
凝血酶原2是凝血酶的直接前体,可通过凝血酶原1经有限的胰蛋白酶或活性因子X蛋白水解作用获得。在没有酶的情况下,凝血酶原1不会转化为凝血酶原2。研究表明,因子V对凝血酶原2生成凝血酶的速率没有影响,且凝血酶原本身没有凝血或酯酶活性。静脉注射凝血酶原2制剂会导致血浆复钙时间、总体纤溶活性和非酶性纤维蛋白溶解增加。此外,还观察到纤维蛋白原 - 肝素复合物活性显著增加。所获得的数据表明,静脉注射小剂量凝血酶原2会激发抗凝系统。